A major advance in cancer study is arising with the use of VHH fragments to reactivate damaged p53. This crucial cancer suppressor protein is frequently inactivated in several types of tumors, causing uncontrolled https://7prbookmarks.com/story22021976/mini-antibodies-reactivate-p53-new-new-pathway-for-malignant-treatment